Cases 51 - 60 of 76
Biogen International GmbH et al v. Hetero USA Inc. et al
as 1:2017cv00825
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Hetero USA Inc. , Hetero Labs Limited Unit-III and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271
Kowa Company, Ltd. et al v. Hetero Drugs Limited et al
as 1:2017cv00762
Plaintiff:
Kowa Company, Ltd. , Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.
Defendant:
Hetero Drugs Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271
OSI Pharmaceuticals, LLC et al v. Hetero USA Inc. et al
as 1:2017cv00665
Plaintiff:
OSI Pharmaceuticals, LLC and Genentech, Inc.
Defendant:
Hetero USA Inc., Hetero Labs Ltd. and Hetero Labs Ltd. Unit-V
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Hetero USA Inc. et al
as 1:2017cv00376
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit-V
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Aurobindo Pharma USA Inc.
as 1:2017cv00374
Defendant:
Aurobindo Pharma USA Inc., Indoco Remedies Ltd., Dr. Reddy's Laboratories Inc. and others
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Hetero USA Inc. et al
as 1:2017cv00031
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Hetero USA Inc. and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Hetero USA Inc. et al
as 1:2016cv00928
Plaintiff:
Amgen Inc.
Defendant:
Hetero USA Inc., Hetero Labs Ltd. and Hetero Labs Ltd. Unit V
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Amneal Pharmaceuticals et al
as 1:2016cv00853
Defendant:
Aurobindo Pharma Ltd, Cadila Healthcare Ltd. doing business as Zydus Cadila, Hetero USA Inc. and others
Plaintiff:
Amgen Inc.
3Rd Party Defendant:
Alkem Laboratories Ltd. and Ascend Laboratories, LLC
Counter Claimant:
Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Hetero USA Inc. et al
as 1:2016cv00452
Plaintiff:
UCB, Inc. , UCB Biopharma SPRL , Research Corporation Technologies, Inc. and others
Defendant:
Hetero USA Inc. and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271
AbbVie Inc. et al v. Hetero USA Inc. et al
as 1:2015cv00889
Plaintiff:
AbbVie Inc. and Abbvie Deutschland GMBH & Co. KG
Defendant:
Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit-III
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
